Objective: To develop a scale to measure self-efficacy in neurologically impaired patients with multiple sclerosis and to assess the scale' s psychometric properties.
Design: Cross-sectional questionnaire study in a clinical setting, the retest questionnaire returned by mail after completion at home.
Setting: Regional multiple sclerosis (MS) outpatient clinic or the Clinical Trials Unit (CTU) at a large neuroscience centre in the UK.
Subjects: One hundred persons with MS attending the Walton Centre for Neurology and Neurosurgery and Clatterbridge Hospital, Wirral, as outpatients.
Methods: Cognitively impaired patients were excluded at an initial clinic assessment. Patients were asked to provide demographic data and complete the self-efficacy scale along with the following validated scales: Hospital Anxiety and Depression Scale, Rosenberg Self-Esteem Scale, Impact, Stigma and Mastery and Rankin Scales. The Rankin Scale and Barthel Index were also assessed by the physician.
Results: A new 11-item self-efficacy scale was constructed consisting of two domains of control and personal agency. The validity of the scale was confirmed using Cronbach' s alpha analysis of internal consistency (α = 0.81). The test–retest reliability of the scale over two weeks was acceptable with an intraclass correlation coefficient of 0.79. Construct validity was investigated using Pearson' s product moment correlation coefficient resulting in significant correlations with depression (r = –0.52) anxiety (r = –0.50) and mastery (r = 0.73). Multiple regression analysis demonstrated that these factors accounted for 70% of the variance of scores on the self-efficacy scale, with scores on mastery, anxiety and perceived disability being independently significant.
Conclusion: Assessment of the psychometric properties of this new selfefficacy scale suggest that it possesses good validity and reliability in patients with multiple sclerosis. Address for correspondence: SJ Smith, Astley Ainslie Hospital, 133 Grange Loan, Edinburgh EH9 2HL, Scotland, UK.
Get full access to this article
View all access options for this article.
References
1.
Stenager E, Knudsen L, Jensen K. Multiple sclerosis: the impact of physical impairment and cognitive dysfunction on social and spare-time activities. Psychother Psychosom1991; 56: 123–128.
2.
Russo J, Katon W, Lin E et al. Neuroticism and extroversion as predictors of health outcomes in depressed primary care patients. Psychosomatics1997; 38(4): 339–348.
3.
Bremer GF, Melamed BG, Pannish RS. Optimism and coping as determinents of psychosexual adjustment to rheumatoid arthritis. J Clin Psychol Med Settings1994; 1(2): 115–134.
4.
Antonak RF, Livneh H. Psychosocial adaptation to disability and its investigation among persons with multiple sclerosis. Soc Sci Med1995; 40(8): 1099–1108.
5.
Smith SJ, Appleton JEV, Kennedy JD. The contributions of affect and adequacy of community services on perceived disability in adults with physical difficulties. Eur J Neurol1996; 3(2): 41–41.
6.
Bandura A. Human agency in social cognitive theory. Am Psychol1989; 44(9): 1175–1184.
7.
Macleod L, Macleod G. Control cognitions and psychological disturbance in people with contrasting physically disabling conditions. Disabil Rehabil1998; 20 (12); 448–456.
8.
Wassem R. Self efficacy as a predictor of adjustment to multiple sclerosis. J Neurosci Nursing1992; 25(4): 224–299.
9.
Barnwell AM, Kavanagh DJ. Prediction of psychological adjustment to multiple sclerosis. Soc Sci Med1997; 45(3): 411–418.
10.
Schwartz CE, Coulthard-Morris L, Zeng Q, Retzlaff P. Measuring self-efficacy in people with multiple sclerosis: a validation study. Arch Phys Med Rehabil1996; 77: 394–398.
11.
Tedman S, Thornton E, Baker GA. Development of a scale to measure core beliefs and perceived selfefficacy in adults with epilepsy. Seizure1995; 4: 221–231.
12.
Collin C, Wade DT, Davis S, Horne V. The Barthel ADL index: a reliability study. Int Disabil Stud1988; 10: 61–63.
13.
Rankin J. Cerebral vascular accidents in patients over the age of 60 years. 2. Prognosis. Scot Med J1957; 2: 200–215.
14.
Zigmund AS, Snaith RP. The Hospital Anxiety and Depression Scale. Acta Psychiatr1983; 67: 361–370.
15.
Rosenberg M. Society and the adolescent self image. Princeton, NJ: Princeton University Press, 1965.
16.
Pearlin LI, Scholler C. The structure of coping. J Health Soc Behav19: 2–21.
17.
Schiaffino KM. Assessing the impact of self-efficacy beliefs on adaptation to rheumatoid arthritis. Arthritis Care Res1991; 4(4): 150–157.
18.
Hobart JC, Lamping DL, Thompson AJ. Evaluating neurological outcome measures: the bare essentials. J Neurol Neurosurg Psychiatry1996; 60: 127–130.
19.
Bland JM, Altman DG. Statistical methods for assessing agreement between two methods of clinical measurement. The Lancet1986; 1; 307–310.
20.
Cronbach LJ. Coefficient alpha and the internal structure of tests. Psychometrica1951; 16: 297–334.
21.
Smith SJ, Young CA. The role of affect on the perception of disability in multiple sclerosis. Clin Rehabil2000; 14: 50–54.
22.
Shnek AM, Foley FW, La Rocca et al. Helplessness, self-efficacy, cognitive distortions and depression in multiple sclerosis and spinal cord injury. Ann Behav Med1997; 19(3): 287–294.
